My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 210

    1.

    Inhibiting glycosphingolipid synthesis improves glycemic control and insulin sensitivity in animal models of type 2 diabetes.

    Zhao H, Przybylska M, Wu IH, Zhang J, Siegel C, Komarnitsky S, Yew NS, Cheng SH.

    Diabetes. 2007 May;56(5):1210-8.PMID: 17470562 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Modulation of adipoinsular axis in prediabetic zucker diabetic fatty rats by diazoxide.

    Alemzadeh R, Tushaus KM.

    Endocrinology. 2004 Dec;145(12):5476-84. Epub 2004 Aug 19.PMID: 15319354 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Inhibiting glycosphingolipid synthesis ameliorates hepatic steatosis in obese mice.

    Zhao H, Przybylska M, Wu IH, Zhang J, Maniatis P, Pacheco J, Piepenhagen P, Copeland D, Arbeeny C, Shayman JA, Aerts JM, Jiang C, Cheng SH, Yew NS.

    Hepatology. 2009 Jul;50(1):85-93.PMID: 19444873 [PubMed - indexed for MEDLINE]Related articles

    4.

    Beta-glycosphingolipids improve glucose intolerance and hepatic steatosis of the Cohen diabetic rat.

    Zigmond E, Zangen SW, Pappo O, Sklair-Levy M, Lalazar G, Zolotaryova L, Raz I, Ilan Y.

    Am J Physiol Endocrinol Metab. 2009 Jan;296(1):E72-8. Epub 2008 Oct 21.PMID: 18940939 [PubMed - indexed for MEDLINE]Related articles

    5.

    Development and characterization of a novel rat model of type 2 diabetes mellitus: the UC Davis type 2 diabetes mellitus UCD-T2DM rat.

    Cummings BP, Digitale EK, Stanhope KL, Graham JL, Baskin DG, Reed BJ, Sweet IR, Griffen SC, Havel PJ.

    Am J Physiol Regul Integr Comp Physiol. 2008 Dec;295(6):R1782-93. Epub 2008 Oct 1.PMID: 18832086 [PubMed - indexed for MEDLINE]Related articles

    6.

    Use of glycated hemoglobin to assess Glycemic control in Wistar diabetic fatty rats and Zucker fatty rats.

    Albright AL, Johnson PR, Greene S, Stern JS.

    Obes Res. 1994 Nov;2(6):535-9.PMID: 16358402 [PubMed - indexed for MEDLINE]Related articles

    7.

    Capsaicin-sensitive sensory fibers in the islets of Langerhans contribute to defective insulin secretion in Zucker diabetic rat, an animal model for some aspects of human type 2 diabetes.

    Gram DX, Ahrén B, Nagy I, Olsen UB, Brand CL, Sundler F, Tabanera R, Svendsen O, Carr RD, Santha P, Wierup N, Hansen AJ.

    Eur J Neurosci. 2007 Jan;25(1):213-23.PMID: 17241282 [PubMed - indexed for MEDLINE]Related articles

    8.

    A nonspecific phosphotyrosine phosphatase inhibitor, bis(maltolato)oxovanadium(IV), improves glucose tolerance and prevents diabetes in Zucker diabetic fatty rats.

    Winter CL, Lange JS, Davis MG, Gerwe GS, Downs TR, Peters KG, Kasibhatla B.

    Exp Biol Med (Maywood). 2005 Mar;230(3):207-16.PMID: 15734724 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Effects of a novel glycogen synthase kinase-3 inhibitor on insulin-stimulated glucose metabolism in Zucker diabetic fatty (fa/fa) rats.

    Cline GW, Johnson K, Regittnig W, Perret P, Tozzo E, Xiao L, Damico C, Shulman GI.

    Diabetes. 2002 Oct;51(10):2903-10.PMID: 12351425 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Recurrent intermittent restraint delays fed and fasting hyperglycemia and improves glucose return to baseline levels during glucose tolerance tests in the Zucker diabetic fatty rat--role of food intake and corticosterone.

    Bates HE, Kiraly MA, Yue JT, Goche Montes D, Elliott ME, Riddell MC, Matthews SG, Vranic M.

    Metabolism. 2007 Aug;56(8):1065-75.PMID: 17618951 [PubMed - indexed for MEDLINE]Related articles

    11.

    Infliximab restores glucose homeostasis in an animal model of diet-induced obesity and diabetes.

    Araújo EP, De Souza CT, Ueno M, Cintra DE, Bertolo MB, Carvalheira JB, Saad MJ, Velloso LA.

    Endocrinology. 2007 Dec;148(12):5991-7. Epub 2007 Aug 30.PMID: 17761768 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Effect of Withania somnifera on insulin sensitivity in non-insulin-dependent diabetes mellitus rats.

    Anwer T, Sharma M, Pillai KK, Iqbal M.

    Basic Clin Pharmacol Toxicol. 2008 Jun;102(6):498-503. Epub 2008 Mar 16.PMID: 18346053 [PubMed - indexed for MEDLINE]Related articles

    13.

    Pharmacological inhibition of glucosylceramide synthase enhances insulin sensitivity.

    Aerts JM, Ottenhoff R, Powlson AS, Grefhorst A, van Eijk M, Dubbelhuis PF, Aten J, Kuipers F, Serlie MJ, Wennekes T, Sethi JK, O'Rahilly S, Overkleeft HS.

    Diabetes. 2007 May;56(5):1341-9. Epub 2007 Feb 7.PMID: 17287460 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    The male obese Wistar diabetic fatty rat is a new model of extreme insulin resistance.

    Greene SF, Johnson PR, Eiffert KC, Greenwoodt MR, Stern JS.

    Obes Res. 1994 Sep;2(5):432-43.PMID: 16358398 [PubMed - indexed for MEDLINE]Related articles

    15.

    Metabolic and endocrine effects of interleukin-1 in obese, diabetic Zucker fa/fa rats.

    del Rey A, Monge-Arditi G, Klusman I, Besedovsky HO.

    Exp Clin Endocrinol Diabetes. 1996;104(4):317-26.PMID: 8886749 [PubMed - indexed for MEDLINE]Related articles

    16.

    JTT-501, a novel oral antidiabetic agent, improves insulin resistance in genetic and non-genetic insulin-resistant models.

    Shibata T, Matsui K, Yonemori F, Wakitani K.

    Br J Pharmacol. 1998 Dec;125(8):1744-50.PMID: 9886766 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Sensory nerve desensitization by resiniferatoxin improves glucose tolerance and increases insulin secretion in Zucker Diabetic Fatty rats and is associated with reduced plasma activity of dipeptidyl peptidase IV.

    Gram DX, Hansen AJ, Deacon CF, Brand CL, Ribel U, Wilken M, Carr RD, Svendsen O, Ahrén B.

    Eur J Pharmacol. 2005 Feb 21;509(2-3):211-7.PMID: 15733558 [PubMed - indexed for MEDLINE]Related articles

    18.

    Effect of a series of novel sulphonylthioureas on glucose tolerance in the obese fa/fa Zucker rat.

    Farrar NS, Chambers NJ, Carlsson AR, Denyer G, Johnston GA.

    Clin Exp Pharmacol Physiol. 2001 May-Jun;28(5-6):386-91.PMID: 11380511 [PubMed - indexed for MEDLINE]Related articles

    19.

    Characterization of STZ-Induced Type 2 Diabetes in Zucker Fatty Rats.

    Okamoto T, Kanemoto N, Ohbuchi Y, Okano M, Fukui H, Sudo T.

    Exp Anim. 2008 Jul;57(4):335-45.PMID: 18633156 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    L-cysteine supplementation lowers blood glucose, glycated hemoglobin, CRP, MCP-1, and oxidative stress and inhibits NF-kappaB activation in the livers of Zucker diabetic rats.

    Jain SK, Velusamy T, Croad JL, Rains JL, Bull R.

    Free Radic Biol Med. 2009 Jun 15;46(12):1633-8. Epub 2009 Mar 26.PMID: 19328229 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity